SIS3

产品说明书

Print
Chemical Structure| 521984-48-5 同义名 : SIS3 HCl
CAS号 : 521984-48-5
货号 : A170854
分子式 : C28H28ClN3O3
纯度 : 99%+
分子量 : 489.993
MDL号 : MFCD09265258
存储条件:

Pure form Sealed in dry,2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 120 mg/mL(244.9 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:

IP 2% DMSO+2% Tween80+30% PEG300+water 7 mg/mL clear

PO 0.5% CMC-Na 28 mg/mL suspension

生物活性
描述 Smads are a family of proteins with similar structure that mediates the numerous effects of the transforming growth factor beta (TGF-β) superfamily, which are critically important for tissue regeneration and homeostasis[1]. The specific inhibitor of Smad3 (SIS3) is a synthesized chemical that specifically inhibits Smad3 with IC50 value of 3 μM[2].
A549 cells were treated with 3 μM of SIS3 for 4h prior to 5 ng/mL TGF-β1 exposure for 48 hours. SIS3 markedly decreased the expression of p-Smad3 that was induced by TGF-β1 but did not affect total Smad3 expression as examined by western blotting assay. The results from immunofluorescence assay also indicated that the A549 cells had an obvious nuclear expression of p-Smad3 with a spindle-shaped-like morphology when treated with TGF-β1 only. However, after the pre-treatment with SIS3, the TGF-β1-induced morphological changes were not significant and the fluorescence intensity of p-Smad3 was weakened mainly in the nucleus[3].
In ureteral obstruction (UUO) BALB/c mouse model, 0.2 and 2 mg/kg of SIS3 was intraperitoneally injected to the mice daily for 1 week, and on the 8th post-operation day, the kidney was harvested. The phosphorylation levels of Smad3 were remarkably decreased after treating with SIS3 and the signal ligand TGF-β1 also showed suppression in a dose dependent level measured by western blotting assay[4].
作用机制 SIS3 can specifically inhibits Smad3 phosphorylation and its binding to Smad4 [4] .
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.04mL

0.41mL

0.20mL

10.20mL

2.04mL

1.02mL

20.41mL

4.08mL

2.04mL

参考文献

[1]Macias MJ, Martin-Malpartida P, et al. Structural determinants of Smad function in TGF-β signaling. Trends Biochem Sci. 2015;40(6):296-308.

[2]Jinnin M, Ihn H, et al. Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol. 2006;69(2):597-607.

[3]Wang X, Gao JL, et al. Therapeutic effects of conditioned medium from bone marrow-derived mesenchymal stem cells on epithelial-mesenchymal transition in A549 cells. Int J Mol Med. 2018;41(2):659-668.

[4]Ji X, Wang H, et al. Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling. Med Sci Monit. 2018.